Literature DB >> 20458334

Fatigue in primary biliary cirrhosis.

Ghulam Abbas1, Roberta A Jorgensen, Keith D Lindor.   

Abstract

Primary biliary cirrhosis (PBC) is a chronic, autoimmune, cholestatic liver disease with a slowly progressive course. Without treatment, most patients eventually develop fibrosis of the liver and may need liver transplantation in the late stage of disease. Fatigue and pruritus are the most common symptoms of PBC, but the majority of patients are asymptomatic at first presentation. There is no specific treatment for fatigue in PBC, but modafinil has shown some potential beneficial effects, such as increased energy levels and decreased total sleep time. This Review article discusses the natural history and the measurement of fatigue in patients with PBC. The central and the peripheral mechanisms that have been suggested for the pathogenesis of fatigue in PBC are also discussed and treatment options are reviewed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458334     DOI: 10.1038/nrgastro.2010.62

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  80 in total

1.  Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C.

Authors:  L Kleinman; M W Zodet; Z Hakim; J Aledort; C Barker; K Chan; L Krupp; D Revicki
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 2.  The pruritus of cholestasis.

Authors:  Nora V Bergasa
Journal:  J Hepatol       Date:  2005-10-06       Impact factor: 25.083

Review 3.  The experience of women with primary biliary cirrhosis: a literature review.

Authors:  S Fahey
Journal:  J Adv Nurs       Date:  1999-08       Impact factor: 3.187

4.  Design and implementation of magnetization transfer pulse sequences for clinical use.

Authors:  J V Hajnal; C J Baudouin; A Oatridge; I R Young; G M Bydder
Journal:  J Comput Assist Tomogr       Date:  1992 Jan-Feb       Impact factor: 1.826

5.  Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.

Authors:  M A Babatin; F M Sanai; M G Swain
Journal:  Aliment Pharmacol Ther       Date:  2006-09-01       Impact factor: 8.171

6.  Epidemiology and natural history of primary biliary cirrhosis in a US community.

Authors:  W R Kim; K D Lindor; G R Locke; T M Therneau; H A Homburger; K P Batts; B P Yawn; J L Petz; L J Melton; E R Dickson
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

7.  Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment.

Authors:  M G Swain; M Maric
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

8.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

9.  Ghrelin/Leptin-imbalance in patients with primary biliary cirrhosis.

Authors:  M Breidert; T F Zimmermann; R Schneider; G Ehninger; G Brabant
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-03       Impact factor: 2.949

10.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

View more
  12 in total

1.  A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

Authors:  Fernanda Q Onofrio; Gideon M Hirschfield; Aliya F Gulamhusein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-03

Review 2.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Inflammation and the Silent Sequelae of Stroke.

Authors:  Kyra J Becker
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 4.  Biobehavioral Mechanisms Associated With Nonhealing Wounds and Psychoneurologic Symptoms (Pain, Cognitive Dysfunction, Fatigue, Depression, and Anxiety) in Older Individuals With Chronic Venous Leg Ulcers.

Authors:  Joyce K Stechmiller; Debra Lyon; Gregory Schultz; Daniel J Gibson; Michael T Weaver; Diana Wilkie; Anastasiya V Ferrell; Joanne Whitney; Junglyun Kim; Susan B Millan
Journal:  Biol Res Nurs       Date:  2019-05-29       Impact factor: 2.522

Review 5.  Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.

Authors:  Victoria Menzies; Nancy Jallo; Patricia Kinser; Jo Lynne W Robins; Kyungeh An; Carolyn Driscoll; Angela Starkweather; Jasmohan S Bajaj; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2014-07-18       Impact factor: 2.522

Review 6.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

7.  Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms.

Authors:  Michele M Tana; Hawwa Alao; Nevitt Morris; Shanna Bernstein; Jacob Hattenbach; Rahiya B Rehman; Robert Brychta; Souvik Sarkar; Xiongce Zhao; Mary Walter; Ashura Buckley; Kong Chen; Yaron Rotman
Journal:  Fatigue       Date:  2017-12-03

Review 8.  Managing Sleep Disturbances in Cirrhosis.

Authors:  Xun Zhao; Philip Wong
Journal:  Scientifica (Cairo)       Date:  2016-05-03

Review 9.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

Review 10.  Importance of fatigue and its measurement in chronic liver disease.

Authors:  Lynn H Gerber; Ali A Weinstein; Rohini Mehta; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.